Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

213.56
+2.731.29%
Post-market: 214.490.9300+0.44%19:57 EDT
Volume:2.68M
Turnover:573.86M
Market Cap:10.65B
PE:33.83
High:215.61
Open:211.55
Low:211.06
Close:210.83
52wk High:217.06
52wk Low:136.89
Shares:49.85M
Float Shares:49.85M
Volume Ratio:1.59
T/O Rate:5.38%
Dividend:0.41
Dividend Rate:0.19%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.31
PE(LYR):-142.95

Loading ...

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
Aug 08

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Aug 08

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08

Sanofi, Regeneron Seem Keen to Keep Working Together

Dow Jones
·
Aug 07

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 07

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

TIPRANKS
·
Aug 07

ArborGen cancels CEO long-term incentive shares after departure

TIPRANKS
·
Aug 07

Biogen completes acquisition of RayThera

TIPRANKS
·
Aug 07

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 07

Sector Update: Healthcare

MT Newswires Live
·
Aug 07

Regeneron Posts Transcript of Q2 2026 Earnings Conference Call

Reuters
·
Aug 07

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

TIPRANKS
·
Aug 07

Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma

Reuters
·
Aug 06

Regeneron announces Health Canada approval of new indication for Libtayo

TIPRANKS
·
Aug 06

Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

THOMSON REUTERS
·
Aug 06

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Dow Jones
·
Aug 06

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Reuters
·
Aug 06